2021
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer
Punekar S, Griffin M, Masri L, Roman S, Makarov D, Sherman S, Becker D. Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer. American Journal Of Clinical Oncology 2021, 44: 597-602. PMID: 34753883, DOI: 10.1097/coc.0000000000000875.Peer-Reviewed Original ResearchConceptsStage IV colorectal cancerKRAS testingColorectal cancerMedicaid insuranceMultivariable-adjusted Cox proportional hazards modelsStage IV colorectal adenocarcinomaEpidermal growth factor receptor monoclonal antibodiesCox proportional hazards modelMultivariable logistic regression modelAdvanced colorectal cancerEnd Results (SEER) databaseRisk of deathReceptor monoclonal antibodyProportional hazards modelWild-type KRASSocioeconomic disparities persistLogistic regression modelsCRC patientsResults databaseColorectal adenocarcinomaKRAS mutationsHigher median household incomeHazards modelPatientsMolecular testing
2020
Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database
Punekar S, Kaakour D, Masri-Lavine L, Hajdu C, Newman E, Becker D. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database. American Journal Of Clinical Oncology 2020, 43: 846-849. PMID: 32910023, DOI: 10.1097/coc.0000000000000761.Peer-Reviewed Original ResearchConceptsG3 neuroendocrine tumorsColorectal neuroendocrine tumorsNeuroendocrine tumorsOverall survivalUnmarried patientsCox proportional hazards modelEnd Results (SEER) databaseGastrointestinal neuroendocrine tumorsPredictors of survivalPrognosis of patientsNational registry studyProportional hazards modelOlder patientsRegistry studySEER databaseWorse survivalMedian ageSurveillance EpidemiologyBlack patientsResults databaseTumor characteristicsHazards modelPatientsSmall studyLogistic regression
2019
Characterization of a novel entity of high-grade well-differentiated colorectal neuroendocrine tumors.
Punekar S, Masri-Lavine L, Hajdu C, Newman E, Becker D. Characterization of a novel entity of high-grade well-differentiated colorectal neuroendocrine tumors. Journal Of Clinical Oncology 2019, 37: e15696-e15696. DOI: 10.1200/jco.2019.37.15_suppl.e15696.Peer-Reviewed Original ResearchOverall survivalNeuroendocrine tumorsCarcinoid tumorsSmall cell neuroendocrine tumorsCox proportional hazards modelColorectal carcinoid tumorsEnd Results (SEER) databaseDemographics of patientsPredictors of survivalColorectal neuroendocrine tumorsNew pathologic entityProportional hazards modelPatient demographicsMedian ageSurveillance EpidemiologyBlack patientsResults databaseTumor characteristicsPathologic entityTumor gradeGI tractHazards modelPatientsSmall studyTumors